Your browser doesn't support javascript.
loading
PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFß Inhibitors.
Kwon, Minsuk; Kim, Chang Gon; Lee, Hoyoung; Cho, Hyunsoo; Kim, Youngun; Lee, Eung Chang; Choi, Seong Jin; Park, Junsik; Seo, In-Ho; Bogen, Bjarne; Song, Ik-Chan; Jo, Deog-Yeon; Kim, Jin Seok; Park, Su-Hyung; Choi, Inhak; Choi, Yoon Seok; Shin, Eui-Cheol.
Afiliação
  • Kwon M; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Kim CG; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Lee H; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Cho H; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
  • Kim Y; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Lee EC; Advanced Research Center for Multiple Myeloma, Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Choi SJ; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Park J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Seo IH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Bogen B; Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Song IC; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
  • Jo DY; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
  • Park SH; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Choi I; Advanced Research Center for Multiple Myeloma, Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea. ecshin@kaist.ac.kr wyfran@cnu.ac.kr miccih@inje.ac.kr.
  • Choi YS; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea. ecshin@kaist.ac.kr wyfran@cnu.ac.kr miccih@inje.ac.kr.
  • Shin EC; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. ecshin@kaist.ac.kr wyfran@cnu.ac.kr miccih@inje.ac.kr.
Clin Cancer Res ; 26(7): 1644-1655, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31941832

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Receptores de Antígenos de Linfócitos T / Fator de Crescimento Transformador beta / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / Receptores de Antígenos de Linfócitos T / Fator de Crescimento Transformador beta / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article